Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases

“Diffuse midline glioma (DMG), H3K27M-mutant” was newly classified in the revised World Health Organization (WHO) 2016 classification of central nervous system tumors. Spinal cord DMG, H3K27M-mutant is relatively rare, with poor prognosis, and there are no effective treatment protocols. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: YABUNO, Satoru, KAWAUCHI, Satoshi, UMAKOSHI, Michiari, UNEDA, Atsuhito, FUJII, Kentaro, ISHIDA, Joji, OTANI, Yoshihiro, HATTORI, Yasuhiko, TSUBOI, Nobushige, KOHNO, Shohei, NOUJIMA, Mai, TOJI, Tomohiro, YANAI, Hiroyuki, YASUHARA, Takao, DATE, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769434/
https://www.ncbi.nlm.nih.gov/pubmed/35079510
http://dx.doi.org/10.2176/nmccrj.cr.2021-0033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769434/
https://www.ncbi.nlm.nih.gov/pubmed/35079510
http://dx.doi.org/10.2176/nmccrj.cr.2021-0033

Ejemplares similares